Combatting the Opioid Crisis with Technology with Justin Zenanko CEO of SynerFuse

In this episode we're joined by Justin Zenanko, CEO and co-founder of SynerFuse to discuss groundbreaking technique combining spinal fusion and direct nerve stimulation to treat chronic low back pain, aiming to eliminate the need for postoperative opioids. Justin delves into the inspiration behind the technology, its clinical results, and the company's approach to quality and regulatory management. He also provides insights on raising funds in a competitive market and the potential future applications of SynerFuse's technology.Justin's BioJustin Zenanko, CPA, MDiv, is the president, CEO, and co-founder of SynerFuse, Inc., a Minnesota-based company innovating the spine industry with its integrated approach which combines spinal fusion and direct nerve stimulation to address the chronic low back pain that is unaddressed in about 40% of the 500,000 traditional spinal fusion surgeries that take place annually in the US alone. The SynerFuse approach aims to eliminate the post-surgical need for addictive opioids. Link to SynerFuse website: https://www.synerfuse.com/00:00 Introduction and Welcome00:41 Meet Justin Zinenko: From CPA to MedTech Innovator03:16 The Birth of SynerFuse: Combining Spinal Fusion with Nerve Stimulation05:29 Clinical Results and Patient Success Stories08:46 Quality and Regulatory Approaches in MedTech10:29 Future Applications and Innovations14:59 Advice for Aspiring Entrepreneurs17:51 Fun Insights and Closing Remarks Qualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez